dc.contributor.author | Ozkurt, C. U. | |
dc.contributor.author | Ozguroglu, M. | |
dc.contributor.author | Selcukbiricik, F. | |
dc.contributor.author | Mandel, N. Molinas | |
dc.contributor.author | Demirelli, FUAT HULUSİ | |
dc.contributor.author | Erdamar, S. | |
dc.contributor.author | Buyukunal, E. | |
dc.contributor.author | Tural, D. | |
dc.contributor.author | Serdengecti, S. | |
dc.date.accessioned | 2021-03-06T19:53:32Z | |
dc.date.available | 2021-03-06T19:53:32Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | Selcukbiricik F., Erdamar S., Ozkurt C. U. , Mandel N. M. , Demirelli F. H. , Ozguroglu M., Tural D., Buyukunal E., Serdengecti S., "The role of K-RAS and B-RAF mutations as biomarkers in metastatic colorectal cancer", JOURNAL OF BUON, cilt.18, ss.116-123, 2013 | |
dc.identifier.issn | 1107-0625 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_f8614f1c-4963-4a77-a22e-c942716217bb | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/162703 | |
dc.description.abstract | Purpose: Unlike cetuximab, there is a paucity of biomarkers for bevacizumab as predictors of outcome in metastatic colorectal cancer (mCRC) patients. Obviously exploring the worth of some potential markers in this setting is warranted. The purpose of this study was to investigate the predictive value of the presence of K-RAS and B-RAF mutations on the outcome of patients with mCRC treated with FOLFIRI and bevacizumab combination therapy. | |
dc.language.iso | eng | |
dc.subject | Tıp | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.title | The role of K-RAS and B-RAF mutations as biomarkers in metastatic colorectal cancer | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF BUON | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 18 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 116 | |
dc.identifier.endpage | 123 | |
dc.contributor.firstauthorID | 14616 | |